Elicio Therapeutics, Inc.
ELTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$52 | -$35 | -$28 | -$26 |
| Dep. & Amort. | $1 | $1 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $1 | $1 | $1 |
| Change in WC | $4 | -$0 | -$0 | $1 |
| Other Non-Cash | $8 | $0 | $5 | $1 |
| Operating Cash Flow | -$37 | -$33 | -$22 | -$24 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$1 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $20 | $10 | $0 | $14 |
| Stock Issued | $6 | $7 | $0 | $0 |
| Stock Repurch. | $0 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $17 | $22 | $21 | $5 |
| Financing Cash Flow | $42 | $39 | $21 | $19 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $5 | $6 | -$2 | -$5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14 | $8 | $10 | $15 |
| End Cash | $19 | $14 | $8 | $10 |
| Free Cash Flow | -$37 | -$33 | -$23 | -$24 |